News
Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...
Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...
German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...
Bayer said on Wednesday it had cut about 12,000 full-time positions since the start of a restructuring programme to speed up decision-making and reduce managerial and administrative positions. Bayer, ...
On July 31, Bayer (BAYRY) said, “Bayer has established additional provisions of around EUR 1.2B for the Roundup litigation. This figure is ...
The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...
Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...
As cancer lawsuits cut into profits, Roundup-producer Bayer is behind legislation in 12 states and Congress to shield ...
Ordinarily, Bayer’s ownership of the Bayer Leverkusen football team does not factor much into its financial results. Read ...
PROFIT FORECAST: The German pharmaceutical and agricultural conglomerate pre-released preliminary second-quarter numbers last week, announcing group earnings before interest, tax, depreciation, ...
Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results